Matsushima J

No ORCID on file · 3 papers in corpus · active 2025-2026

Study types

  • other 2

Condition tags

  • endometriosis 2
2026
Durable complete remission of pulmonary metastases with bevacizumab plus olaparib maintenance therapy in homologous recombination–deficient gynecologic large-cell neuroendocrine carcinoma: A case report
Gynecologic oncology reports ·doi:10.1016/j.gore.2026.102114

Gynecologic neuroendocrine carcinoma (NEC) is a rare and aggressive malignancy with limited treatment options and poor prognosis. Homologous recombination deficiency (HRD) is an established predictive biomarker for poly(ADP-ribose) polymera…

other 2026
Reply of the Authors: Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial
F&S reports ·doi:10.1016/j.xfre.2025.12.008
other 2025
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial
F&S reports ·doi:10.1016/j.xfre.2025.04.009

OBJECTIVE: To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis. DESIGN: A multicente…